Search Results for: Global Type 2 Diabetes Market
Articles
GLOBAL REPORT - 2017 Global Drug Delivery & Formulation Report: Part 1, a Global Review March 15, 2018
In part 1 of this 4-part series, PharmaCircle in collaboration with Drug Development & Delivery, focuses on the macro aspects of the 2017 product approvals.
SPECIAL FEATURE - Injection Devices: Manufacturers Focus on 21st Century Technology While Still Tackling Traditional Challenges March 14, 2018
Contributor Cindy H. Dubin highlights some of the key companies in the injectable delivery market that are focusing on advanced technology as well as the more traditional challenges related to breakage, leaching, and needlestick prevention.
RespireRx Pharmaceuticals Announces Publication of Phase 2B PACE Study December 6, 2017
RespireRx Pharmaceuticals Inc. recently announced that the results of the PACE (Pharmacotherapy of Apnea by Cannabimimetic Enhancement) clinical trial have...Kamada Presents Updated Data From Phase 2 Clinical Trial for Inhaled Therapy May 30, 2017
Kamada Ltd. recently announced that a poster comprising updated data from the company’s US Phase 2 clinical trial of its...CONTRACT MANUFACTURING - Flexibility in an Evolving Market April 3, 2017
Matthew Moorcroft, PhD, warns that in the fast-moving pharmaceutical industry, change is the only constant. And to keep up with market developments, small molecule manufacturers must first understand the trends.
Next-Generation Silicone Adhesive Technologies Key to Broader Global Adoption, Growth of Wearable Medical Devices February 8, 2017
According to Grand View Research, the global market for wearable medical devices is expected to reach $27.8 billion by 2022.1...PROTEIN THERAPEUTICS MARKET - Technology Advances Spur Market Growth of Protein Therapies November 7, 2016
Laurie L. Sullivan and Shalini S. Dewan, BCC Research Analysts, believe with the advent of genetic engineering and recombinant DNA technology, it is now possible to produce a wide variety of human proteins, and that these novel technologies have lifted the market for therapeutic proteins to new heights.
Allergan to Acquire Tobira Therapeutics, Expanding Global GI R&D Pipeline & Taking a Leading R&D Position in NASH September 25, 2016
Allergan plc recently announced it has entered into a definitive agreement under which Allergan will acquire Tobira for an upfront...Niagara University Faculty Present Groundbreaking Research, New Insulin Pill For Diabetes Patients September 9, 2016
NIAGARA UNIVERSITY, N.Y. - The need for painful insulin injections by certain diabetes patients may be eliminated with the...Major Players in Type 2 Diabetes Shifting Focus to Pricing to Maintain Market Share July 6, 2016
The highly mature type 2 diabetes (T2D) market, which is forecast to be valued at $58.7 billion by 2025, will...Major Players in Type 2 Diabetes Shifting Focus to Pricing to Maintain Market Share July 6, 2016
The highly mature type 2 diabetes (T2D) market, which is forecast to be valued at $58.7 billion by 2025, will...Pharmaceutical Industry Licensing Deals Soared to Record $46.2 Billion in 2015 June 16, 2016
Licensing deal values in the pharmaceutical industry rose by 37.1% year-to-year, from $33.7 billion in 2014 to $46.2 billion in...Pharmaceutical Industry Licensing Deals Soared to Record $46.2 Billion in 2015 June 16, 2016
Licensing deal values in the pharmaceutical industry rose by 37.1% year-to-year, from $33.7 billion in 2014 to $46.2 billion in...New Company Created to Develop Novel Technology to Treat Diabetes May 20, 2016
The Cell and Gene Therapy Catapult (CGT) and University of Aberdeen, UK, recently announced the creation of Islexa, a new...Global Type 1 Diabetes Mellitus Market Value Will Exceed $7 Billion November 24, 2015
The Type 1 Diabetes Mellitus (T1DM) market across the eight major countries of the US, Canada, France, Germany, Italy, Spain,...DRUG DEVICE MARKET - Joining Forces: Global Markets for Drug-Device Combinations November 19, 2015
Kevin James and Kevin Gainer of BCC Research indicate the development of the market for combination products is closely related to the drug delivery systems sector, which represents a vast area of research and the demand for sophisticated drug delivery devices behind many novel product developments.
DIAGNOSTIC TESTING - Diabetes Diagnostic Testing: A Move From Invasive to Non-Invasive Testing November 19, 2015
Divyaa Ravishankar, Frost & Sullivan Analyst, focuses on the innovations around self-monitoring glucose meters and continuous glucose monitoring devices, providing in-depth competitive intelligence on some of the technologies and non-invasive techniques.
Branded Acute Coronary Syndrome Therapies to Grab Market Share From Generic Drugs Globally September 2, 2015
The acute coronary syndrome (ACS) therapeutics market consists of approximately 30 marketed branded drugs and hundreds of generics. While generic...The CDMO Market: Implications of Patheon's IPO June 10, 2015
By: Patricia Van Arnum, DCAT Editorial Director, posted Tue, Jun 09, 2015 04:42 AM Patheon's announcement this week that it plans to...Continuous Glucose Monitoring Market Surging at 19.6% CAGR; R&D Soon to Create Devices for Faster Administration January 28, 2015
BCC Research (www.bccresearch.com) reveals in its new report on continuous glucose monitoring (CGM), the total CGM market is forecast to...Issues
June 2011
When Deals Work - & When They Don't: Large Pharma Strategies for Off-Loading Shuttered Capacity Derek G. Hennecke continues with...
